These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Albendazole in the treatment of strongyloidiasis. Report of 66 cases].
    Author: Coulaud JP, Deluol AM, Cenac J, Rossignol JF.
    Journal: Bull Soc Pathol Exot Filiales; 1982 Nov; 75(5):530-3. PubMed ID: 7165901.
    Abstract:
    Albendazole, a new broad spectrum anthelmintic, has been tested in 66 adult patients infected by S. stercoralis. 77.2% cure rate was observed following 800 mg once a day for 3 consecutive days, based on repeated fecal examinations using a concentration technic (Junod) and a Baermann test, carried out during 6 to 9 months following treatment. Associated ancylostomiasis caused by N. americanus and trichuriasis were also completely cured (100%). Based on clinical side effects and laboratory investigations, the drug did not produce any significant adverse reactions.
    [Abstract] [Full Text] [Related] [New Search]